Accelerating transit times and lowering the cost of comparator sourcing for studies in Africa
To understand why sub-Saharan Africa can appear a daunting prospect to a contract research organisation (CRO) or sponsor looking to…
Oximio SMO Group
Latest in
Oximio SMO Group
Novavax reports preliminary data from Covid-19-influenza vaccine trial
In Phase I/II trial, the combination vaccine was found to be well-tolerated and immunogenic.
Panthera raises funds to expedite expansion of clinical trial sites
The investment proceeds will also be used to enhance Panthera's service offering.
AstraZeneca’s Evusheld offers protection against Covid-19 in Phase III trial
In the six-month follow-up assessment, Evusheld reduced symptomatic Covid-19 development risk by 83% versus placebo.
Synaptogenix concludes subject enrolment in Phase IIb Alzheimer’s trial
Topline results from the trial are anticipated during the fourth quarter of this year.
AI benefits in patient identification and clinical trial recruitment has challenges in sight
AI technology in clinical trials has the potential to speed up cohort selection and patient recruitment. However, data management and…
By
Amgen’s Phase III trial of ABP 654 meets primary efficacy endpoint
The trial assessed the safety and efficacy of ABP 654 versus Stelara in adults with moderate to severe plaque psoriasis.
TCS introduces monitoring solution for clinical trials
The solution enables biopharmaceutical and CROs to detect risks linked to trials and sites using improved statistical algorithms.